The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.

The M12-backed healthcare data management platform is speaking to new investors and is targeting between $50m and $60m at a $300m valuation.

The company has revealed it added approximately $6m to a series A round co-led by AbbVie Ventures last year, bringing its total size to about $59m.

Citi Ventures was among the investors in the series C round, which increased the bookkeeping software provider's overall funding to more than $100m.

Taiho, Memorial Sloan Kettering Cancer Center and Hartford HealthCare contributed to a round that boosted the cancer drug developer's total funding to more than $175m.

The oncology-focused drug developer sourced $77m in the series D round, which was co-led by China Life Healthcare Fund.

Novel, PayPal and Qualcomm-backed Viva Republica almost doubled its valuation to $2.2bn and has now raised more than $260m altogether.

The open-source database developer has now raised more than $108m in total, having secured $55m in a round backed by Alphabet's GV unit.

Novo provided $72m in series E funding for the waste-to-ethanol technology producer, which counts the likes of Mitsui, Siemens and Petronas as existing investors.

Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.